In this study, in addition to investigating the role of EIF3C in NPC, we establish the relationship between EIF3C and infiltrated CD8+ T cells and construct the EIF3C-related CD8+ T-cell signature (ETS) in predicting the prognosis and immunotherapy response of NPC patients. This evidence concerns the gene EIF3C and nasopharyngeal carcinoma.